Salt Lake City, UT (PRWEB) September 18, 2013
TFX Health, LLC teamed up with GNC earlier this year to introduce TFX Flex™, a popular new joint health supplement that many industry insiders expect to revolutionize the joint health industry. In addition to several important vitamins and joint health nutrients, TFX Flex™ contains a breakthrough new dietary ingredient that has been proven in human clinical studies to be 2X more effective than glucosamine & chondroitin for joint pain relief. After months of robust sales at GNC.com, the product is now available in GNC retail outlets nationwide.
According to a TFX Health company spokesman, “GNC is the most important retail distribution channel for health and wellness products in general, and cutting edge new science in particular. The cooperation between the two companies was essential to make TFX Flex™ readily available for those seeking new and improved solutions to joint health problems.”
Both companies share the view that joints can only be as healthy as the bones and muscles to which they are attached. TFX Flex™ combines clinically proven ingredients for bone, joint, and muscle support providing a safe and effective solution for the entire musculoskeletal system. Since its launch earlier this year, TFX Flex™ has become GNC’s best selling triple threat product for bone, joint, and muscle health.
The launch of TFX Flex™ quickly captured the attention of the joint health industry after glucosamine & chondroitin, came under fire in a 2010 study published in the British Medical Journal. The study concluded that, “Glucosamine and chondroitin, either taken together or separately, have not shown a clinically significant improvement in joint pain relief for patients troubled with knee or hip osteoarthritis [BMJ 2010; 341:c4675].
Worldwide annual sales of glucosamine & chondroitin have been estimated at more than $2 billion, with nearly half of that coming from the United States. A spokesman for TFX Health explained, “The science behind joint health is changing and consumers are actively looking for better alternatives. TFX Flex™ has been shown in clinical studies to be 2X more effective than glucosamine & chondroitin and it is the only product on the market that takes an overall approach to bone, muscle, and joint health.”
TFX Flex™ contains a breakthrough new dietary ingredient known as UC-II® Undenatured Type II Collagen that was developed by a team of scientists with more than 25 years of experience in the development of patented, clinically substantiated dietary ingredients. The new ingredient holds 7 international and U.S. patents and is supported by 9 clinical studies, including research at Harvard Medical School.
In one randomized, double-blind, placebo-controlled human clinical study published in the International Journal of Medical Science it was found that only 40 mg of UC-II® was more than two times as effective as 1,500 mg of glucosamine and 1,200 mg of chondroitin in supporting joint health, comfort and flexibility. It outperformed the glucosamine & chondroitin combination in three different joint pain relief assessment tools: WOMAC, VAS and the Lequesne Functional Index. UC-II® significantly decreased joint pain during daily activities, including walking on a flat surface, performing heavy domestic duties, ascending stairs and while resting in bed. UC-II® was also shown to be safe and well tolerated with no known side effects [Int J Med Sci. 2009; 6:312-321].
TFX Flex™ customers are experiencing positive results. J.Monnier, reported, “The usual daily pain in my joints is much less with this product. I noticed a difference by the end of the first week.” M. Jacobsen, explained, “After two knee surgeries, I was skeptical after trying just about everything out there for my knee aches so I’m glad that I gave this a shot as it worked great, and I was feeling results in less than a week.”
About TFX Health, LLC
Based in Salt Lake City, TFX Health, LLC is an innovative pioneer in the development of advanced health and wellness products. All products are manufactured in the USA in FDA registered, GMP compliant facilities and sold worldwide through online and traditional retail channels.
UC-II® is a trademark of InterHealth N.I. Clinical data available upon request. U.S. Patents 5,645,851; 5,637,321; 5,529,786; 5,750,144; 7,083,820; 7,846,487, EPO Patent 1435906B1 and worldwide patents pending.